Clinical Trials Browser

Phase 2 × fluoromisonidazole × 1 year × Clear all

NCT02498613 2025-09-25

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

Phase 2 Active not recruiting

122 enrolled 16 charts

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

Phase 2 Recruiting

Brain Neoplasms